Proteasome inhibition with bortezomib in SLE promotes therapeutically relevant depletion of short- and long-lived plasma cells but does not prevent their regeneration

Authors
Publication date
4 September 2017
Publisher
German Medical Science GMS Publishing House; Düsseldorf
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      German Medical Science

      redirect
      oaioai:oai-gms.dimdi.de:GM17dgrh1...
      Last time updated on 09/07/2019

      Crossref

      redirect
      oaiinfo:doi/10.1136%2Fannrheumdis...
      Last time updated on 06/08/2021